Actively Recruiting
TAMBE Japan Post-Marketing Surveillance
Led by W.L.Gore & Associates · Updated on 2026-05-05
100
Participants Needed
5
Research Sites
413 weeks
Total Duration
On this page
Sponsors
W
W.L.Gore & Associates
Lead Sponsor
C
CMIC Co, Ltd. Japan
Collaborating Sponsor
AI-Summary
What this Trial Is About
To evaluate the safety and efficacy of multi component system (TAMBE device) including GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (Aortic Component; AC) under post-marketing use.
CONDITIONS
Official Title
TAMBE Japan Post-Marketing Surveillance
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who were attempted to implant the AC
- Diagnosis of thoracoabdominal aortic aneurysm
- Diagnosis of pararenal abdominal aortic aneurysm
You will not qualify if you...
- N/A
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
The Jikei University Hospital
Minatoku, Japan
Actively Recruiting
2
Nagoya University Hospital
Nagoya, Japan
Actively Recruiting
3
Morinomiya Hospital
Osaka, Japan
Actively Recruiting
4
Osaka International Medical & Science Center Osaka Police Hospital
Osaka, Japan
Actively Recruiting
5
The University of Osaka Hospital
Suita, Japan
Actively Recruiting
Research Team
K
Katsuyuki Niwa
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here